Weightwatchers: a new partnership with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth.
$WW
WeightWatchers (NASDAQ:WW), a pioneer in science-backed weight management, has announced a enhancement to its member services through a new partnership with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth. This collaboration aims to simplify the process for WeightWatchers Clinic members to access Zepbound® (tirzepatide) single-dose vials, an FDA-approved medication.
Eligible patients who self-pay and do not have insurance coverage can now receive Zepbound® vials with prescriptions from board-certified clinicians directly through the WeightWatchers App. This service not only enhances convenience but also ensures real-time tracking of prescriptions.
Scott Honken, PharmD, Chief Commercial Officer at WeightWatchers, emphasized the company’s commitment to improving access to affordable and evidence-based medications.
“Zepbound vials offer an affordable treatment option for eligible patients without insurance coverage, and its usage continues to rise with our members. With 33% of WeightWatchers Clinic members now using Zepbound as part of their treatment plan and prescriptions for Zepbound vials increasing by over 100% in the past few months, our integration with LillyDirect’s pharmacy provider Gifthealth enables us to improve the fulfillment process and better serve our growing number of members who rely on this medication.”
Robert Hoppe, EVP of Life Sciences at Gifthealth, also commented on the partnership’s benefits, highlighting the goal of removing friction from the pharmacy experience. “Through this integration, we’re enabling real-time prescription tracking, streamlined fulfillment and transparent pricing—removing friction from the pharmacy experience so eligible members can focus on their health goals,” Hoppe explained.
A recent study involving 3,260 WeightWatchers Clinic patients showed that members lost on average 21% of their body weight at 12 months when using GLP-1 medications like Zepbound in conjunction with WeightWatchers’ lifestyle support program. By integrating advanced clinical interventions with its #1 doctor-recommended Points® Program and extensive community solutions more accessible and effective for its members, further solidifying its position as a global leader in the industry.
**DISCLAIMER: THIS CONTENT IS FOR INFORMATIONAL PURPOSES ONLY AND SHOULD NOT BE INTERPRETED AS INVESTMENT ADVICE. INVESTING INVOLVES RISK, INCLUDING THE POTENTIAL LOSS OF PRINCIPAL. READERS ARE ENCOURAGED TO CONDUCT THEIR OWN RESEARCH AND CONSULT WITH A QUALIFIED FINANCIAL ADVISOR BEFORE MAKING ANY INVESTMENT DECISIONS.**